Management of Cardiotoxicity Associated With Breast Cancer Therapy
 

I sat in on the teleconference hosted by Dr. Dennis Slamon today and would highly recommend it to others. It will be repeated today, tomorrow and next week.

BC patients who were in the adjuvant trials should also attend as it may alter their outlook of continuing Herceptin while still in remission.

What was interesting was that cardiotoxicity from A/C is usually permanent but is reversable when caused by Herceptin, but recovery may take longer than previously thought.

http://registration.clinicaloptions....toxicity_2006/

Regards
Joe

unable to attend
 

Joe,

I will not be able to attend any of the teleconferences, but would be very interest in information, especially in light of your suggestion that "it may alter their outlook of continuing Herceptin while still in remission." I am continuing on Herceptin in the adjuvant setting while in remission.

Is there another way to access the information from the teleconference?
________
COLORADO DISPENSARIES

also unable to attend
 

Joe,
I live in France and also will not attend but would welcome the information or a summary of it particualrly since I'm 2 years into herceptin.
thanks
sarah
PS great site! well done!

Thanks....
 

..for all your efforts on our behalf.
________
thai property in Pattaya

I will contact htem to see if they will send me a transcript.


Regards
Joe

Clinical Options has responded to my email. They will post the discussion on their website sometimes after 9/27.

They promised to email me when it is posted.

Regards
Joe

Thanks loads Joe. I see my onc on the 5th and want to have all info I can gather.
________
ROLL BLUNTS